fluoxymesterone sold brand names halotestin ultandren among others androgen anabolic steroid aas medication used treatment low testosterone levels men delayed puberty boys breast cancer women taken side effects fluoxymesterone include symptoms masculinization like acne increased hair growth voice changes increased sexual also cause liver damage cardiovascular side effects like high blood drug synthetic androgen anabolic steroid hence agonist androgen receptor ar biological target androgens like testosterone dihydrotestosterone strong androgenic effects moderate anabolic effects make useful producing fluoxymesterone first described introduced medical use addition medical use fluoxymesterone used improve physique drug controlled substance many countries nonmedical use generally fluoxymesterone used treatment hypogonadism delayed puberty anemia males treatment breast cancer specifically approved one countries treatment hypogonadism men delayed puberty boys breast cancer current prescribing guidelines united states list treatment androgen deficiency males breast cancer females fluoxymesterone less effective inducing masculinization testosterone useful maintaining established masculinization fluoxymesterone available form mg oral fluoxymesterone used physique performanceenhancing purposes competitive athletes bodybuilders side effects associated fluoxymesterone include acne edema seborrheaseborrheic dermatitis alopecia hirsutism voice deepening virilization general flushing gynecomastia breast pain menstrual disturbances hypogonadism testicular atrophy clitoral enlargement penile enlargement priapism increased aggressiveness prostate enlargement cardiovascular toxicity hepatotoxicity among aas fluoxymesterone agonist androgen receptor ar similarly androgens like testosterone substrate like testosterone potentiated socalled androgenic tissues like skin hair follicles prostate gland via transformation fluoxymesterone relatively poor ratio anabolic androgenic activity similarly testosterone however fluoxymesterone nonetheless proportionally less androgenic anabolic methyltestosterone fluoxymesterone reported nonaromatizable due steric hindrance hydroxyl hence considered propensity producing estrogenic effects gynecomastia fluid however paradoxically case report severe fluoxymesteroneinduced gynecomastia exists gynecomastia associated fluoxymesterone also reported publications although may due estrogenic fluoxymesterone thought possess little progestogenic presence group metabolism fluoxymesterone impeded resulting orally active although also fluoxymesterone found act potent inhibitor dehydrogenase type halfmaximal inhibitory concentration nm potency comparable inhibitor glycyrrhetinic action fluoxymesterone unique among aas likely related responsible inactivation glucocorticoids cortisol corticosterone cortisone inhibition fluoxymesterone may result mineralocorticoid receptor overactivation associated side effects hypertension fluid retention hypothesized involved cardiovascular adverse effects unlike aas fluoxymesterone structural features common corticosteroids including fluoro hydroxyl relation weak micromolar potentially clinically significant affinity glucocorticoid fluoxymesterone approximately oral bioavailability unlike testosterone methyl group fluoxymesterone inhibits firstpass low affinity human serum sex hormonebinding globulin shbg less testosterone less drug metabolized liver mainly known active metabolites include fluoxymesterone elimination halflife approximately hours long relative eliminated urine less excreted fluoxymesterone also known synthetic androstane steroid derivative testosterone specifically derivative testosterone fluorine atom position hydroxyl group position methyl group step one first step synthesis fluoxymesterone microbiological oxidation commercially available androstenedione actinomyces introduces hydroxyl group oxidised ketone using jones reagent yielding adrenosterone pyrrolidine reacts form enamine reaction group protecting alkylation subsequent step regioselectivity pyrrolidine reaction occurs inherently structure adrenosterone due position sterically bulky methyl groups subsequent steps alkylation group using grignard reagent addition hydride regeneration protected group yields starting material final steps fluoxymesterone synthesis involves standard synthetic transformations step two starting material sulfonylated ptoluenesulfonyl chloride addition trimethylamine base deprotonates yielding elimination tosylate pka give olefin stereospecificity reaction olefin hypobromous acid hobr base nbromosuccinimide nbs determined formation bromonium intermediate electrophilic bromonium cation approaches rings less sterically hindered αface attacked πelectron density alkene hydroxide ion attacks ring βface resulting structure stereospecific addition hydroxyl bromine across double bond addition sodium hydroxide results deprotonation subsequent structure undergoes intramolecular epoxy ring formation epoxy ring βepoxide protonated give oxironium ion intermediate concerted process fluoride attacks rings αface one two oxygencarbon bonds broken opposite face hence regenerating trans fluorine substituent resulting structure androgenic steroid fluoxymesterone detection halotestin illegal anabolic steroids sports achieved gsms identification urinary excreted anabolic steroids metabolites test halotestin dry residue obtained urine sample dissolved dimethylformamide sulfur trioxidepyridine complex heated potassium carbonate solution halotestin many metabolites contain two polar hydroxyl groups leading intermolecular hydrogen bonding increases boiling point reduces volatility order attain gaseous sample gcms products hydrolysis extracted dissolved methanol derivatised form volatile trimethylsilyl tms esters adding nmethylntrimethylsilyltrifluoroacetamide mstfa trimethylsilylimidazole fluoxymesterone first described introduced medical use united states time use fluoxymesterone become increasingly controversial fluoxymesterone generic name drug inntooltip international nonproprietary name usptooltip united states pharmacopeia bantooltip british approved name dcittooltip denominazione comune italiana jantooltip japanese accepted name fluoxymestérone dcftooltip dénomination commune brand names fluoxymesterone include androidf androxy halotestin oratestryl ultandren among fluoxymesterone one aas remains available medical use united others august testosterone testosterone cypionate testosterone enanthate testosterone undecanoate methyltestosterone availability fluoxymesterone aside united states remains scarce marketed countries mexico moldova fluoxymesterone along aas schedule iii controlled substance united states controlled substances httpsenwikipediaorgwikifluoxymesterone